brain Archive — Page 12 of 17
-
January 23, 2015
New view of dopamine heteromers
Although heteromeric dopamine receptors composed of both D1 and D2 subunits have been proposed to play a role in depression and schizophrenia, recent studies suggest these heteromers do not exist. -
January 8, 2015
Curcumin’s ability to fight Alzheimer’s studied
One of the most promising new treatments for Alzheimer’s disease may already be in your kitchen. Curcumin, a natural product found in the spice turmeric, has been used by many Asian cultures for centuries, and a new study indicates a close chemical analog of curcumin has properties that may make it useful as a treatment for the brain disease. -
December 18, 2014
Family’s gift bolsters schizophrenia research, treatment
A “transformational” $6.4 million gift from Dallas couple Donald Test Jr., and his wife, Charlotte, who have a very personal connection to the devastating disease of schizophrenia, is supporting Vanderbilt Department of Psychiatry research and treatment into schizophrenia and related disorders. -
November 20, 2014
New protocol for young brain injury patients shows success
A new protocol put into place more than a year ago at Monroe Carrell Jr. Children’s Hospital at Vanderbilt is showing early signs of improving outcomes for patients with traumatic brain injuries. -
November 6, 2014
Optogenetics sheds new light on brain’s behavior modulators
A new light-based technology is allowing scientists to peer deep into the brain and alter animal behavior with the “flip of a switch.” -
October 20, 2014
New faculty: Dugan explores complexities of Alzheimer’s
Laura Dugan strives to bring breakthroughs in neuroscience research and the aging brain together. -
September 18, 2014
VU study reveals shared pathways in psychiatric disorders
Schizophrenia and bipolar disorder share common genetic underpinnings. Vanderbilt researchers combined high-resolution gene expression studies with gene association data to reveal signaling pathways linked to schizophrenia and bipolar disorder.